Skip to main content
Clinical Trials/IRCT20100314003566N15
IRCT20100314003566N15
Recruiting
Phase 2

Evaluation of the effectiveness of botulinum toxin in preventing hypertrophic scarring at the site of surgical wounds on the trunk, limbs and neck

Tabriz University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tabriz University of Medical Sciences
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients between 18 and 80 years of age with recent history of trunk, neck or extremity surgery in less than 10 days
  • Insensitivity to botulinum toxin
  • Consent to participate in the research project
  • Scar site with at least 2 cm

Exclusion Criteria

  • History of allergy to botulinum toxin
  • Pregnancy or breastfeeding
  • Recent botulinum injection within 6 months
  • History of radiotherapy and chemotherapy
  • History of wound healing disorder
  • History of recent surgery at the current site of surgery
  • Any other cosmetic procedure at the surgical site, including laser or filler injection
  • Myasthenia gravis and other neuromuscular disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials